• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Mortality Up for Children With Leukemia From Lowest SES Neighborhoods

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 28, 2025.

THURSDAY, Aug. 28, 2025 -- Children with acute lymphoblastic leukemia (ALL) from the lowest socioeconomic status (SES) neighborhoods have an increased risk for mortality, according to a study published online Aug. 22 in Blood Advances.

Anna L. Hoppmann, M.D., M.P.H., from the University of South Carolina School of Medicine in Columbia, and colleagues used the National Cancer Database to examine the impact of area-level SES on overall survival among children with ALL in a retrospective cohort study. A composite area-level SES variable was created using median income and education quartiles based on residential zip code.

The cohort included 17,044 children with ALL (57 percent male; 61 percent non-Hispanic White). Overall, 12 and 18 percent resided in the lowest and highest SES neighborhoods, respectively. The researchers found that children in the lowest SES neighborhoods had a 55 percent increased hazard of all-cause mortality compared with those in the highest SES neighborhoods. Among those from the lowest SES neighborhoods, the increased hazard of mortality persisted in those who survived two and five years (hazard ratios, 1.70 and 1.87, respectively).

"There has been increasing recognition of SES as a driver of persistent inequities within pediatric oncology and the need for ongoing efforts to address them," the authors write. "The present findings illustrate that area-level SES-associated vulnerabilities persist during off-therapy follow-up among children with ALL."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.